EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

PERIOPERATIVE ANTICOAGULATION MANAGEMENT: A HEMATOLOGIST–CARDIOLOGIST PERSPECTIVE ON RISK STRATIFICATION AND THERAPEUTIC DRUG MONITORING

Emmanuel Ifeanyi Obeagu, Olga Goryacheva

Universal Journal of Pharmaceutical Research · 15.11.2026

DOI: 10.22270/ujpr.v11i5.1673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Universal Journal of Pharmaceutical Research, online erschienen am 15.11.2026. Verfasst von Emmanuel Ifeanyi Obeagu und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Direct oral anticoagulants (DOACs) are widely used for thromboprophylaxis in atrial fibrillation and venous thromboembolism. Their marketing emphasizes predictable pharmacokinetics and no need for routine monitoring. However, the perioperative period exposes critical limitations of this paradigm, especially in high‑risk populations excluded from landmark trials. This narrative review integrates hematology and cardiology perspectives. We critically examined real‑world evidence on perioperative DOAC management, focusing on patients with extreme body weight, renal or hepatic impairment, active malignancy, thrombocytopenia, bariatric surgery, and drug–drug interactions. Guideline recommendations and commercial influences were analyzed. Routine therapeutic drug monitoring (TDM) is unnecessary for low‑risk elective procedures in standard patients. However, selective TDM is essential in high‑risk populations where DOAC pharmacokinetics are unpredictable. We identified specific indications for TDM (extreme body weight, CrCl

Zitieren

APA

Obeagu, E. I., & Goryacheva, O. (2026). PERIOPERATIVE ANTICOAGULATION MANAGEMENT: A HEMATOLOGIST–CARDIOLOGIST PERSPECTIVE ON RISK STRATIFICATION AND THERAPEUTIC DRUG MONITORING. Universal Journal of Pharmaceutical Research. https://doi.org/10.22270/ujpr.v11i5.1673

Vancouver

Obeagu EI, Goryacheva O. PERIOPERATIVE ANTICOAGULATION MANAGEMENT: A HEMATOLOGIST–CARDIOLOGIST PERSPECTIVE ON RISK STRATIFICATION AND THERAPEUTIC DRUG MONITORING. Universal Journal of Pharmaceutical Research. 2026. doi:10.22270/ujpr.v11i5.1673

BibTeX
@article{Obeagu2026,
  author = {Obeagu, Emmanuel Ifeanyi and Goryacheva, Olga},
  title = {PERIOPERATIVE ANTICOAGULATION MANAGEMENT: A HEMATOLOGIST–CARDIOLOGIST PERSPECTIVE ON RISK STRATIFICATION AND THERAPEUTIC DRUG MONITORING},
  journal = {Universal Journal of Pharmaceutical Research},
  year = {2026},
  doi = {10.22270/ujpr.v11i5.1673}
}
Kostenlos starten →